ES2099304T3 - Mitogeno de la musculatura lisa y adn que lo codifica. - Google Patents

Mitogeno de la musculatura lisa y adn que lo codifica.

Info

Publication number
ES2099304T3
ES2099304T3 ES93101871T ES93101871T ES2099304T3 ES 2099304 T3 ES2099304 T3 ES 2099304T3 ES 93101871 T ES93101871 T ES 93101871T ES 93101871 T ES93101871 T ES 93101871T ES 2099304 T3 ES2099304 T3 ES 2099304T3
Authority
ES
Spain
Prior art keywords
mythogen
dna
codes
amino
smooth musculature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93101871T
Other languages
English (en)
Inventor
Moses Judah Folkmann
Yuen Shing
Koichi Igarashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Boston Children's Hospital
Original Assignee
Takeda Chemical Industries Ltd
Boston Children's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, Boston Children's Hospital filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2099304T3 publication Critical patent/ES2099304T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN FACTOR DE CRECIMIENTO DE MAMIFEROS RECOMBINANTE Y NO GLICOSILATICO (BTC-GF) ESTIMULA LA PROLIFERACION DE CELULAS DE MUSCULO LISO EN LOS HUMANOS. ESPECIALMENTE LA SECUENCIA DEL ACIDO AMINO DE LA PROTEINA DEDUCIDO DE LA CODIFICACION DE LA SECUENCIA DE NUCLEOTIDOS PARA BTC-GF HUMANO ES COMO LA QUE ABARCA LOS ACIDOS AMINO N INO N NO DE LA PROTEINA DEDUCIDA DE LA CODIFICACION DE LA SECUENCIA DE NUCLEOTIDOS DEL BTC-GF DE RATONES ES COMO LA QUE ABARCA LOS ACIDOS AMINO N
ES93101871T 1992-02-10 1993-02-06 Mitogeno de la musculatura lisa y adn que lo codifica. Expired - Lifetime ES2099304T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US83355292A 1992-02-10 1992-02-10
US83293992A 1992-02-10 1992-02-10
US87259792A 1992-04-23 1992-04-23
US87279292A 1992-04-23 1992-04-23
US99477692A 1992-12-22 1992-12-22
US712693A 1993-01-21 1993-01-21

Publications (1)

Publication Number Publication Date
ES2099304T3 true ES2099304T3 (es) 1997-05-16

Family

ID=27555565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93101871T Expired - Lifetime ES2099304T3 (es) 1992-02-10 1993-02-06 Mitogeno de la musculatura lisa y adn que lo codifica.

Country Status (7)

Country Link
EP (1) EP0555785B1 (es)
JP (1) JP3621431B2 (es)
AT (1) ATE145939T1 (es)
CA (1) CA2089111C (es)
DE (1) DE69306273T2 (es)
DK (1) DK0555785T3 (es)
ES (1) ES2099304T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0817842A1 (en) 1995-03-24 1998-01-14 Takeda Chemical Industries, Ltd. Antibody to human betacellulin and use thereof
DE69626034T2 (de) * 1995-11-09 2003-08-14 Takeda Chemical Industries, Ltd. Zusammensetzung für verbesserung der pankreasfunktion
AUPP031897A0 (en) * 1997-11-12 1997-12-04 Gropep Pty Ltd Mammalian milk growth factor
DK1148129T3 (da) * 1998-12-09 2007-10-15 Takeda Pharmaceutical Modifikation af betacellulin
CA2609728A1 (en) * 2005-05-27 2006-11-30 Five Prime Therapeutics, Inc. Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
ATE122358T1 (de) * 1990-10-26 1995-05-15 Childrens Medical Center Glatter muskel mitogen.

Also Published As

Publication number Publication date
DE69306273D1 (de) 1997-01-16
ATE145939T1 (de) 1996-12-15
JP3621431B2 (ja) 2005-02-16
DE69306273T2 (de) 1997-04-03
DK0555785T3 (da) 1997-05-26
EP0555785B1 (en) 1996-12-04
EP0555785A1 (en) 1993-08-18
JPH0687894A (ja) 1994-03-29
CA2089111C (en) 2004-08-03
CA2089111A1 (en) 1993-08-11

Similar Documents

Publication Publication Date Title
EP0591914A3 (en) Retrovirus of the hiv-group and its application
DE69230993D1 (de) Rekombinante viren vektoren zur expression in muskelzellen
EP0448704A4 (en) Osteogenic devices
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
EP0607297A4 (en) Hormone analogs with multiple ctp extensions.
IT8119760A0 (it) Polipeptide prodotto microbiologicamente con la sequenza di aminoacidi dell'interferone umano, dna e plasmidi che codificano per questa sequenza, microorganismi che contengono queste informazioni genetiche e processo per la loro preparazione.
DE3280400D1 (de) Oligonukleotides heilmittel und dessen herstellungsverfahren.
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
HU9200548D0 (en) Improved activity process of recombined proteins
IL74947A (en) Analogs of human gamma interferon having the partial sequence of human gamma interferon and genetic engineering process for the preparation thereof
EP0825996A4 (en) THE FIBROBLASTED GROWTH FACTOR HOMOLOGOUS FACTOR-1 (FHF-1) AND METHODS FOR ITS USE
IL75788A (en) Peptide comprising a repeated sequence of four amino acids,which sequence occurs in plasmodium falciparum circumsporozoite protein
AU7426487A (en) Method of treating depression using d-fenfluramine
DE68921674D1 (de) Peptide, deren Verwendung als Immuno-Suppressanten und Verfahren zu deren Herstellung.
IL98273A0 (en) Dna sequences,proteins having esterase activity coded by them,and use of such proteins
EP0587571A4 (en) HUMAN GALANINE, cDNA CLONES ENCODING HUMAN GALANINE AND PROCESS FOR PRODUCING HUMAN GALANINE.
ATE209252T1 (de) Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
EP0315118A3 (en) Dna coding for endothelin and use thereof
DE3781667D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
ATE116685T1 (de) Aminopeptidase.
EP0919621A4 (en) HUMAN TAK1 AND DNA CODING THEM
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555785

Country of ref document: ES